Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challenges.

IF 3.9 3区 医学 Q1 HEALTH CARE SCIENCES & SERVICES
Laura Flight, Alan Brennan, Stephen E Chick, Martin Forster, Steven Julious, Puvan Tharmanathan
{"title":"Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challenges.","authors":"Laura Flight, Alan Brennan, Stephen E Chick, Martin Forster, Steven Julious, Puvan Tharmanathan","doi":"10.1186/s12874-025-02566-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Value-adaptive designs for clinical trials are a novel set of emerging methods for delivering greater value for clinical research. There is increasing interest in using them within publicly funded health systems. A value-adaptive design permits 'in progress' changes to be made to the trial according to criteria which reflect its overall value to the healthcare system, including the cost-effectiveness of the technologies under investigation, the cost of running the trial and the total health benefit delivered to patients. These trial designs offer the potential to explicitly balance the costs and benefits of adaptive clinical trials with the health economic benefits expected for populations that are affected by any subsequent health technology adoption decisions. They may also improve the expected value of learning from the budget that is spent within a trial.</p><p><strong>Main body: </strong>This paper introduces value-adaptive designs for publicly funded clinical trials. It discusses the idea of delivering 'value for money' in health technology assessment, what is meant by being 'value-adaptive' and the key features that characterise these designs. The methodology behind one kind of value-adaptive design - the value-based sequential model of a two-armed clinical trial proposed by Chick et al. (2017) - is described and illustrated using three retrospective case studies from the United Kingdom. The paper concludes by reviewing a range of perspectives provided by stakeholders, together with our own thoughts, on the practical opportunities and changes required for implementing a value-adaptive approach.</p><p><strong>Conclusions: </strong>Value-adaptive clinical trial designs offer the potential to align health research funding allocations with population health economic goals. Many of the systems required to deploy value-adaptive designs within a publicly funded health system already exist and, with increased application, experience, and refinement they have the potential to deliver improved value for money.</p>","PeriodicalId":9114,"journal":{"name":"BMC Medical Research Methodology","volume":"25 1","pages":"153"},"PeriodicalIF":3.9000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12139198/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Medical Research Methodology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12874-025-02566-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Value-adaptive designs for clinical trials are a novel set of emerging methods for delivering greater value for clinical research. There is increasing interest in using them within publicly funded health systems. A value-adaptive design permits 'in progress' changes to be made to the trial according to criteria which reflect its overall value to the healthcare system, including the cost-effectiveness of the technologies under investigation, the cost of running the trial and the total health benefit delivered to patients. These trial designs offer the potential to explicitly balance the costs and benefits of adaptive clinical trials with the health economic benefits expected for populations that are affected by any subsequent health technology adoption decisions. They may also improve the expected value of learning from the budget that is spent within a trial.

Main body: This paper introduces value-adaptive designs for publicly funded clinical trials. It discusses the idea of delivering 'value for money' in health technology assessment, what is meant by being 'value-adaptive' and the key features that characterise these designs. The methodology behind one kind of value-adaptive design - the value-based sequential model of a two-armed clinical trial proposed by Chick et al. (2017) - is described and illustrated using three retrospective case studies from the United Kingdom. The paper concludes by reviewing a range of perspectives provided by stakeholders, together with our own thoughts, on the practical opportunities and changes required for implementing a value-adaptive approach.

Conclusions: Value-adaptive clinical trial designs offer the potential to align health research funding allocations with population health economic goals. Many of the systems required to deploy value-adaptive designs within a publicly funded health system already exist and, with increased application, experience, and refinement they have the potential to deliver improved value for money.

有效提供公共资助试验的价值适应性临床试验设计——方法、案例研究、机遇和挑战的讨论。
背景:临床试验的价值适应性设计是一套为临床研究提供更大价值的新方法。人们越来越有兴趣在公共资助的卫生系统内使用它们。价值适应性设计允许根据反映其对医疗保健系统的总体价值的标准对试验进行“正在进行”的更改,包括正在研究的技术的成本效益、运行试验的成本和向患者提供的总健康效益。这些试验设计提供了明确平衡适应性临床试验的成本和收益与受任何后续卫生技术采用决策影响的人群预期的卫生经济效益的潜力。它们还可以提高从试验中花费的预算中学习的预期价值。正文:本文介绍了公共资助临床试验的价值适应性设计。它讨论了在卫生技术评估中提供“物有所值”的想法,什么是“价值适应性”,以及这些设计的主要特征。一种价值适应性设计背后的方法——Chick等人(2017)提出的双臂临床试验的基于价值的顺序模型——使用来自英国的三个回顾性案例研究进行了描述和说明。本文最后回顾了利益相关者提供的一系列观点,以及我们自己对实施价值适应性方法所需的实际机会和变化的看法。结论:价值适应性临床试验设计提供了使卫生研究经费分配与人口健康经济目标保持一致的潜力。在公共资助的卫生系统中部署价值适应性设计所需的许多系统已经存在,并且随着应用、经验和改进的增加,它们有可能提供更高的资金价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Medical Research Methodology
BMC Medical Research Methodology 医学-卫生保健
CiteScore
6.50
自引率
2.50%
发文量
298
审稿时长
3-8 weeks
期刊介绍: BMC Medical Research Methodology is an open access journal publishing original peer-reviewed research articles in methodological approaches to healthcare research. Articles on the methodology of epidemiological research, clinical trials and meta-analysis/systematic review are particularly encouraged, as are empirical studies of the associations between choice of methodology and study outcomes. BMC Medical Research Methodology does not aim to publish articles describing scientific methods or techniques: these should be directed to the BMC journal covering the relevant biomedical subject area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信